Citadel Advisors
JHMH

Citadel Advisors’s John Hancock Multifactor Healthcare ETF JHMH Stock Holding History

Citadel Advisors’s Portfolio JHMH Stock Details JHMH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-4,681
Closed -$202K – 16019
2022
Q3 		$202K Buy
+4,681
New +$216K ﹤0.01% 10388
2021
Q1 		– Sell
-7,458
Closed -$322K – 13923
2020
Q4 		$322K Buy
7,458
+605
+9% +$25.3K ﹤0.01% 8951
2020
Q3 		$274K Buy
6,853
+261
+4% +$10.3K ﹤0.01% 8282
2020
Q2 		$248K Buy
+6,592
New +$243K ﹤0.01% 8223
2019
Q2 		– Sell
-10,920
Closed -$374K – 10098
2019
Q1 		$374K Sell
10,920
-1,484
-12% -$49.8K ﹤0.01% 7272
2018
Q4 		$391K Buy
+12,404
New +$419K ﹤0.01% 6813

Citadel Advisors's JHMH Position: Q4 2022 in Review

Citadel Advisors sold out of John Hancock Multifactor Healthcare ETF (JHMH) in Q4 2022, closing a stake of 4,681 shares — an estimated $202K sold.

Citadel Advisors first reported a position in JHMH in Q4 2018 and held it in 6 quarters. The position peaked at $391K in Q4 2018. 0 funds tracked by Wall St. Rank hold JHMH as of Q4 2022.

  • Citadel Advisors reported no remaining John Hancock Multifactor Healthcare ETF position as of Q4 2022 after selling out during the quarter.
  • Citadel Advisors sold 4,681 John Hancock Multifactor Healthcare ETF shares in Q4 2022, an estimated $202K.
  • Citadel Advisors first reported a position in John Hancock Multifactor Healthcare ETF in Q4 2018 and held it in 6 quarters.
  • Citadel Advisors's John Hancock Multifactor Healthcare ETF position peaked at $391K in Q4 2018.
  • 0 funds tracked by Wall St. Rank held John Hancock Multifactor Healthcare ETF as of Q4 2022.

Based on Citadel Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.